	销售和管理费用		日
Acadia Pharmaceuticals	USD 160.79M	14.06M	2026-03
Adma Biologics	USD 26.74M	6.55M	2026-03
ALKERMES	USD 264.59M	77.4M	2026-03
Alterity Therapeutics Limited	AUD 1.45M	703.96K	2025-12
AstraZeneca	USD 5.06B	455M	2026-03
BioCryst Pharmaceuticals	USD 95.78M	12.77M	2025-12
Bristol-Myers Squibb	USD 1.62B	564M	2026-03
Cipla	INR 13.25B	101.8M	2025-12
Clal Biotechnology	ILS 3.31M	513K	2022-12
Compugen	USD 2.43M	222K	2026-03
CSL	USD 1.23B	498M	2025-12
Eli Lilly	USD 2.93B	198M	2026-03
Esperion Therapeutics	USD 39.42M	456K	2025-12
GlaxoSmithKline	GBP 2.12B	558M	2026-03
Grifols	EUR 320.45M	12.65M	2025-12
Halozyme Therapeutics	USD 46.29M	18.35M	2026-03
Ionis Pharmaceuticals	USD 151M	21M	2026-03
J&J	USD 6.03B	719M	2026-03
Merck	USD 2.67B	180M	2026-03
Minerva Neurosciences	USD 2.48M	58.79K	2024-09
Neurocrine Biosciences	USD 318.5M	16.7M	2026-03
Novartis	USD 3.14B	296M	2026-03
Novavax	USD 25.53M	1.34M	2025-12
Pfizer	USD 2.92B	1.16B	2026-03
Roche Holding	CHF 7.28B	3.99B	2025-12
Sanofi	EUR 2.33B	419M	2026-03
Takeda	JPY 292B	9.21B	2026-03
Vanda Pharmaceuticals	USD 39.28M	1.71M	2024-12